MELISSA CHEHADE: Open Payments
NPI 1396589214 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $75 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $167 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| Exact Sciences Corporation | 4 | $81 |
| Novo Nordisk Inc | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| ABBVIE INC. | 1 | $33 |
| Pulmonx Corporation | 1 | $26 |
| Boston Scientific Corporation | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: ZEPBOUND, JARDIANCE, Cologuard Collection Kit, Ozempic, XIFAXAN, VRAYLAR, CHARTIS CATHETER, General - Pain Management.
Industry payments across CO — which companies pay providers there.
